Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N. Wasko, Miroslav Sekulic, Kristina Drizyte‐Miller et al.|Nature|2024Cited by 175
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophagesSamantha B. Kemp, Marina Pasca di Magliano|Life Science Alliance|2021Cited by 138
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N. Wasko, Kenneth P. Olive, Jingjing Jiang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 11
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N. Wasko, Miroslav Sekulic, Jingjing Jiang et al.|Nature|2024Cited by 5
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerPriya S. Hibshman, David Wildes, Robert H. Vonderheide et al.|UNC Libraries|2024Cited by 0